It is important to note that even in the absence of T2DM, low-grade inflammation induced by the hypercholesterolemic (HC) conditions could stimulate the TNFα-NFκB pathway leading to SHP-2 expression and monocyte activation. Here, NFKB1 is linked to type 2 diabetes mellitus.